Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens

Programmed cell death 1 (PD-1)/programmed cell death 1 ligand (PD-L1) blockade has shown promising effects in cancer immunotherapy. Removing the so-called " brakes” on T cell immune responses by blocking the PD-1/PD-L1 check point should boost anti-tumor immunity and provide durable tumor regre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chin J Cancer Res
Hlavní autoři: Song, Mengjia, Chen, Xinfeng, Wang, Liping, Zhang, Yi
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5953954/
https://ncbi.nlm.nih.gov/pubmed/29861603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2018.02.01
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky